Identification |
Name: | 4-Pyrimidinecarboxamide,2-(1-amino-1-methylethyl)-N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo- |
Synonyms: | 2-(1-Amino-1-methylethyl)-N-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide;(1-Hydroxy-3-isohexenyl)naphthazarine; |
CAS: | 518048-03-8 |
Molecular Formula: | C16H19FN4O3 |
Molecular Weight: | 334.3455 g/mol |
InChI: | InChI=1/C16H19FN4O3/c1-16(2,18)15-20-11(12(22)14(24)21(15)3)13(23)19-8-9-4-6-10(17)7-5-9/h4-7,22H,8,18H2,1-3H3,(H,19,23) |
Molecular Structure: |
|
Properties |
Density: | 1.35 g/cm3 |
Refractive index: | 1.607 |
Appearance: | White solid (powder) |
Specification: |
2-(1-Amino-1-methylethyl)-N-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide , its cas register number is 518048-03-8. It also can be called 2-(2-Aminopropan-2-yl)-N-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide ; and 4-Pyrimidinecarboxamide, 2-(1-amino-1-methylethyl)-N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo- .
|
Storage Temperature: | Refrigerator |
Usage: | An intermediate in the preparation of HIV-integrase inhibitors |
Safety Data |
|
|